Internal Medicine News - Generic versions of osteoarthritis drug
The Food and Drug Administration has approved the first generic versions of Mobic (meloxicam) for the treatment of osteoarthritis. The new approvals of 13 generic meloxicam applications stem from the agency’s cluster review approach, aimed at increasing efficiency and decreasing review time for generic drugs.
Related Results
MobicMobicMobic approvalMobic escapes boxed warning.MOBIC - Brief Article
In the case of meloxicam, an NSAID, the FDA received more than 20 abbreviated new drug applications.
COPYRIGHT 2006 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
